HLA-A and cancer: To test our hypothesis that NLRC5 expression in cancer cells results in better patient survival, we first probed the RNA-Seq TCGA and microarray database of human OC samples for expression of NLRC5 and its main target genes, including the classical HLA class I (HLA-A-B-C).